article Open AccessTop 1% cited
COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China
Allergy · 2020 · Vol. 75(7) · pp. 1742–1752
Qingxian Cai(Southern University of Science and Technology)Deliang Huang(Southern University of Science and Technology)Pengcheng Ou(Southern University of Science and Technology)Hong Yu(Southern University of Science and Technology)Zhibin Zhu(Southern University of Science and Technology)Xia Zhang(Southern University of Science and Technology)Yinan Su(Southern University of Science and Technology)Zhenghua Ma(Southern University of Science and Technology)Yiming Zhang(Southern University of Science and Technology)Zhiwei Li(Southern University of Science and Technology)Qing He(Southern University of Science and Technology)Lei Liu✉(Southern University of Science and Technology)Yang Fu✉(Southern University of Science and Technology)Jun Chen✉(Southern University of Science and Technology)
Abstract
In a designated hospital outside Hubei Province, COVID-2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease.
Disaster Response and ManagementHealthcare Systems and ReformsPneumonia and Respiratory InfectionsCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakChinaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicinePandemicVirologyBetacoronavirusEnvironmental healthInfectious disease (medical specialty)
MeSH terms
BetacoronavirusCOVID-19SARS-CoV-2COVID-19 Drug TreatmentAdolescentAdultAge FactorsAntiviral AgentsBlood SedimentationC-Reactive ProteinChildChinaFemaleHospitalizationHumans
Funding
- Bill and Melinda Gates Foundation
- Sanming Project of Medicine in Shenzhen
Citations
498
FWCI
92.94
field-weighted impact
References
20
Percentile
100%
vs. same field & year
Citations per year
Cited by
Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases
BMJ Open · 2020 · 429 citations
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection
Critical Care · 2020 · 532 citations
References
Fourth universal definition of myocardial infarction (2018)
European Heart Journal · 2018 · 5,751 citations
EASL Clinical Practice Guidelines: Drug-induced liver injury
Journal of Hepatology · 2019 · 1,079 citations
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
American Journal of Respiratory and Critical Care Medicine · 2019 · 3,438 citations
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
The Lancet · 2020 · 51,571 citations
A Novel Coronavirus from Patients with Pneumonia in China, 2019
New England Journal of Medicine · 2020 · 30,188 citations
First Case of 2019 Novel Coronavirus in the United States
New England Journal of Medicine · 2020 · 6,361 citations
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
New England Journal of Medicine · 2020 · 17,893 citations
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
JAMA · 2020 · 21,111 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
